Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

BACKGROUND: Hepatocholangiocarcinoma (cHCC-ICC) is a rare liver tumour for which no data on chemosensitivity exist. The aims of this multicentre study were to evaluate overall survival (OS), progression-free survival (PFS), and prognostic factors in cHCC-ICC treated by gemcitabine plus platinum as f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Salimon, Maëva, Prieux-Klotz, Caroline, Tougeron, David, Hautefeuille, Vincent, Caulet, Morgane, Gournay, Jérôme, Matysiak-Budnik, Tamara, Bennouna, Jaafar, Tiako Meyo, Manuela, Lecomte, Thierry, Zaanan, Aziz, Touchefeu, Yann
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2018
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808029/
https://ncbi.nlm.nih.gov/pubmed/29169182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados